These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Sier CF; Kubben FJ; Ganesh S; Heerding MM; Griffioen G; Hanemaaijer R; van Krieken JH; Lamers CB; Verspaget HW Br J Cancer; 1996 Aug; 74(3):413-7. PubMed ID: 8695357 [TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours. Rooprai HK; Van Meter T; Rucklidge GJ; Hudson L; Everall IP; Pilkington GJ Int J Oncol; 1998 Dec; 13(6):1153-7. PubMed ID: 9824624 [TBL] [Abstract][Full Text] [Related]
8. 72-kDa and 92-kDa gelatinases in saliva of patients with human immunodeficiency virus infection. Mellanen L; Salo T; Ingman T; Konttinen YT; Lähdevirta J; Sorsa T Acta Odontol Scand; 1998 Jun; 56(3):135-42. PubMed ID: 9688221 [TBL] [Abstract][Full Text] [Related]
9. Localization of matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in normal human and rabbit stomachs. Tatsuguchi A; Fukuda Y; Ishizaki M; Yamanaka N Digestion; 1999; 60(3):246-54. PubMed ID: 10343138 [TBL] [Abstract][Full Text] [Related]
10. Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays. Zucker S; Mancuso P; DiMassimo B; Lysik RM; Conner C; Wu CL Clin Exp Metastasis; 1994 Jan; 12(1):13-23. PubMed ID: 8287615 [TBL] [Abstract][Full Text] [Related]
11. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form. Tamakoshi K; Kikkawa F; Nawa A; Ishikawa H; Mizuno K; Tamakoshi A; Yamagata S; Suganuma N; Tomoda Y Cancer; 1995 Dec; 76(12):2565-71. PubMed ID: 8625086 [TBL] [Abstract][Full Text] [Related]
12. Gelatinolytic and type IV collagenolytic activity in bronchiectasis. Sepper R; Konttinen YT; Sorsa T; Koski H Chest; 1994 Oct; 106(4):1129-33. PubMed ID: 7924484 [TBL] [Abstract][Full Text] [Related]
13. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Davies B; Waxman J; Wasan H; Abel P; Williams G; Krausz T; Neal D; Thomas D; Hanby A; Balkwill F Cancer Res; 1993 Nov; 53(22):5365-9. PubMed ID: 8221672 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276 [TBL] [Abstract][Full Text] [Related]
15. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759 [TBL] [Abstract][Full Text] [Related]
16. Localisation of gelatinase activity in epidermal hoof lamellae by in situ zymography. Mungall BA; Pollitt CC; Collins R Histochem Cell Biol; 1998 Nov; 110(5):535-40. PubMed ID: 9826133 [TBL] [Abstract][Full Text] [Related]
17. Increased amounts of collagenase and gelatinase in porcine myocardium following ischemia and reperfusion. Danielsen CC; Wiggers H; Andersen HR J Mol Cell Cardiol; 1998 Jul; 30(7):1431-42. PubMed ID: 9710810 [TBL] [Abstract][Full Text] [Related]
19. Metalloproteinases and tissue inhibitor of metalloproteinase 1 (TIMP-1) in endometrial flushings from pre- and post-menopausal women and from women with endometrial adenocarcinoma. Laird SM; Dalton CF; Okon MA; Bunning RA; Marshall R; Li TC J Reprod Fertil; 1999 Mar; 115(2):225-32. PubMed ID: 10434927 [TBL] [Abstract][Full Text] [Related]